Surgical treatment for retinoblastoma is limited to enucleation (removal of the eye) or exenteration (removal of the eye and contents of the orbit). Histopathological examination of such specimens yields information which may aff ect decisions about further treatment. This information should be part of the clinical information when considering future management and prognosis.
Standard histopathological reporting of specimens
When histopathologists are dealing with cancer specimens, their reports should include standard and appropriate information items, commonly known as a dataset. In the UK, histopathologists use datasets produced by the Royal College of Pathologists. Data items are reviewed every two years and aligned with the international tumour, node, metastasis, (TNM) classifi cation. The TNM classifi cation for retinoblastoma has recently been updated from TNM7 to TNM8. The newest dataset for retinoblastoma from the Royal College of Pathologists (RCPath), released in early 2018, refl ects the changes in the TNM classifi cation (see p. 34).
Histological high-risk features: rationale
The RCPath dataset for retinoblastoma records whether tumour is present in specifi c structures. Presence of tumour in any of these structures is considered a histological high-risk feature (HHRF). Retinoblastoma specimens with HHRFs indicate that the patient is at higher risk for metastasis (tumour spread) than a patient whose specimen does not have such features.
Detection of HHRFs by the histopathologist infl uences management decisions. The histopathologist examining the specimen should therefore specifi cally seek such features. The structures where tumour presence is regarded as an HHRF are:
• sclera • extraocular structures • retrolaminar optic nerve (including the cut end).
Gross examination of enucleation and exenteration specimens
The RCPath dataset for retinoblastoma includes recommendations for macroscopic examination and sampling of globe and exenteration specimens. Even if resources are limited, it is useful to sample the cut end of the optic nerve separately (if length allows) as well as a 'PO block' (see panel) of the globe. If the globe is being opened fresh to sample tumour for cytogenetics, the optic nerve should be sampled fi rst. This will avoid artefactual contamination.
The sampled optic nerve should be embedded transversely, so that a full cross-section can be evaluated. It can either be embedded on the true resection margin (surgeon's cut end) or the pathologist's cut end, as long as the orientation is known to the reporting pathologist. If there is obvious extraocular extension such as an extrascleral nodule or orbital involvement in an exenteration specimen, the specimen should be sampled in such a way as to confi rm this microscopically. The anterior chamber is the space bounded by the cornea anteriorly, iris leaflets posteriorly and angle/ trabecular meshwork peripherally. Schlemm's canal is not always easy to identify histologically, but lies adjacent to the trabecular meshwork. The ciliary body consists of the pars plicata (ciliary muscle covered internally by a double layer of ciliary epithelium) and the more posterior pars plicata.
Anterior segment and ciliary body Choroid
The choroid lies between Bruch's membrane and the sclera. It consists of a capillary network (choriocapillaris) closer to Bruch's membrane, and a vascular stroma towards the sclera. If retinoblastoma invades the choroid, tumour deposits will be seen beneath Bruch's membrane. Bruch's membrane can be difficult to see. It is highlighted with PAS stain, and the retinal pigment epithelium (RPE) may also be a useful landmark.
It is useful to comment on focal choroidal involvement (deposits measuring <3mm either singly or in aggregate), but this is not an HHRF. HHRF relating to the choroid is defined as: massive choroidal invasion (a deposit ≥3mm in any dimension) or multiple foci of focal choroidal involvement totalling ≥3mm or any full-thickness choroidal involvement (ie touching the sclera).
Optic nerve
A transverse cross-section of the optic nerve which is free from tumour is confirmation that the (surgeon's) cut end is free from tumour. However, retrolaminar optic nerve involvement should also be assessed as it is an HHRF. 
Ciliary body
Checklist for assessing HHRF on microscopy This is a suggested ordering of examination in order to assess whether HHRF are present, with the easiest to detect listed first.
Sclera and extraocular
If extrascleral fibroconnective tissue is fibrotic, it is not always straightforward to discern the difference between partial thickness scleral involvement and extrascleral involvement. However, both are considered HHRFs. 
